CA2258146A1 - Polysaccharides synthetiques, procede pour leur preparation et compositions pharmaceutiques les contenant - Google Patents

Polysaccharides synthetiques, procede pour leur preparation et compositions pharmaceutiques les contenant

Info

Publication number
CA2258146A1
CA2258146A1 CA002258146A CA2258146A CA2258146A1 CA 2258146 A1 CA2258146 A1 CA 2258146A1 CA 002258146 A CA002258146 A CA 002258146A CA 2258146 A CA2258146 A CA 2258146A CA 2258146 A1 CA2258146 A1 CA 2258146A1
Authority
CA
Canada
Prior art keywords
polysaccharides
pharmaceutical compositions
compositions containing
preparing same
synthetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002258146A
Other languages
English (en)
Other versions
CA2258146C (fr
Inventor
Philippe Duchaussoy
Jean-Marc Herbert
Guy Jaurand
Maurice Petitou
Constant Van Boeckel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Sanofi
Philippe Duchaussoy
Jean-Marc Herbert
Guy Jaurand
Maurice Petitou
Constant Van Boeckel
Akzo Nobel Nv
Sanofi-Synthelabo
Sanofi-Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi, Philippe Duchaussoy, Jean-Marc Herbert, Guy Jaurand, Maurice Petitou, Constant Van Boeckel, Akzo Nobel Nv, Sanofi-Synthelabo, Sanofi-Aventis filed Critical Sanofi
Publication of CA2258146A1 publication Critical patent/CA2258146A1/fr
Application granted granted Critical
Publication of CA2258146C publication Critical patent/CA2258146C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

L'invention concerne des polysaccharides de synthèse contenant de 8 à 24 unités monosaccharidiques formées par un enchaînement de disaccharides constitués d'un acide uronique et d'un hexose, ledit polysaccharide étant caractérisé en ce que tous ses groupes hydroxyles sont éthérifiés avec un groupe (C1-C6)alkyle ou estérifiés sous la forme de groupe sulfo, chaque disaccharide étant au moins monoéthérifié; ainsi que leurs sels.
CA002258146A 1996-06-14 1997-06-11 Polysaccharides synthetiques, procede pour leur preparation et compositions pharmaceutiques les contenant Expired - Lifetime CA2258146C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9607457A FR2749849B1 (fr) 1996-06-14 1996-06-14 Polysaccharides synthetiques, procede pour leur preparation et compositions pharmaceutiques les contenant
FR96/07457 1996-06-14
PCT/FR1997/001048 WO1997047659A1 (fr) 1996-06-14 1997-06-11 Polysaccharides synthetiques, procede pour leur preparation et compositions pharmaceutiques les contenant

Publications (2)

Publication Number Publication Date
CA2258146A1 true CA2258146A1 (fr) 1997-12-18
CA2258146C CA2258146C (fr) 2003-10-07

Family

ID=9493087

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002258146A Expired - Lifetime CA2258146C (fr) 1996-06-14 1997-06-11 Polysaccharides synthetiques, procede pour leur preparation et compositions pharmaceutiques les contenant

Country Status (15)

Country Link
US (1) US7919614B2 (fr)
EP (1) EP0904299B1 (fr)
JP (1) JP3501813B2 (fr)
AT (1) ATE204883T1 (fr)
AU (1) AU3266797A (fr)
BR (1) BR9709722B1 (fr)
CA (1) CA2258146C (fr)
CY (1) CY2281B1 (fr)
DE (1) DE69706418T2 (fr)
DK (1) DK0904299T3 (fr)
ES (1) ES2163171T3 (fr)
FR (1) FR2749849B1 (fr)
NO (1) NO319037B1 (fr)
PT (1) PT904299E (fr)
WO (1) WO1997047659A1 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2751334B1 (fr) * 1996-07-19 1998-10-16 Sanofi Sa Polysaccharides synthetiques, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2773804B1 (fr) * 1998-01-19 2000-02-18 Sanofi Sa Polysaccharides de synthese, procede pour leur preparation et compositions pharmaceutiques le contenant
EP1574516A1 (fr) * 2004-03-05 2005-09-14 Sanofi-Aventis Composés antithrombotiques
JP4796758B2 (ja) * 2004-08-24 2011-10-19 学校法人 京都産業大学 組成物及びそれを含有する抗腫瘍剤
TWI403334B (zh) 2004-12-23 2013-08-01 Merck Sharp & Dohme 包含生物素殘基之抗血栓雙重抑制劑
KR101529061B1 (ko) 2008-05-30 2015-06-16 모멘타 파머슈티컬스 인코포레이티드 당류 구조물, 그리고 이러한 구조물의 제조 및 사용 방법
FR2949114B1 (fr) 2009-08-14 2011-08-26 Sanofi Aventis OCTASACCHARIDES N-ACYLES ACTIVATEURS DES RECEPTEURS DES FGFs, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
FR2949115B1 (fr) * 2009-08-14 2012-11-02 Sanofi Aventis OLIGOSACCHARIDES N-SULFATES ACTIVATEURS DES RECEPTEURS DES FGFs, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
FR2970969B1 (fr) * 2011-01-27 2013-10-18 Sanofi Aventis Oligosaccharides 3-o-alkyles activateurs des recepteurs des fgfs, leur preparation et leur application en therapeutique
EP2578594A1 (fr) * 2011-10-04 2013-04-10 Sanofi Procédé pour la préparation de l'acide L-iduronique par une réaction decarboxylation/cyclisation intramoléculaire en tandem
WO2021211441A1 (fr) * 2020-04-13 2021-10-21 The Board Of Regents Of The University Of Oklahoma Polymères du sucre modifiés à faible activité anticoagulante et activité thérapeutique

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5529985A (en) * 1990-04-23 1996-06-25 Akzo Nobel Nv Sulfated glycosaminoglycanoid derivatives of the dermatan sulfate and chondroitin sulfate type
US5382570A (en) * 1990-04-23 1995-01-17 Akzo, N.V. Sulfated glycosaminoglycanoid derivatives of the dermatan sulfate and chondroitin sulfate type
US5378829A (en) * 1990-04-23 1995-01-03 Akzo N.V. Sulfated glycosaminoglycanoid derivatives of the heparin and heparan sulfate type
US5668274A (en) * 1991-04-23 1997-09-16 Akzo Nobel N.V. Sulfated glycosaminoglycanoid derivatives of the dermatan sulfate and chondroitin sulfate type

Also Published As

Publication number Publication date
BR9709722A (pt) 2000-01-25
DK0904299T3 (da) 2001-12-17
ES2163171T3 (es) 2002-01-16
NO985831L (no) 1999-02-11
FR2749849A1 (fr) 1997-12-19
AU3266797A (en) 1998-01-07
CY2281B1 (en) 2003-07-04
DE69706418T2 (de) 2002-05-29
JPH11513061A (ja) 1999-11-09
EP0904299B1 (fr) 2001-08-29
DE69706418D1 (de) 2001-10-04
NO319037B1 (no) 2005-06-06
EP0904299A1 (fr) 1999-03-31
NO985831D0 (no) 1998-12-11
US7919614B2 (en) 2011-04-05
PT904299E (pt) 2002-02-28
US20040068108A1 (en) 2004-04-08
ATE204883T1 (de) 2001-09-15
JP3501813B2 (ja) 2004-03-02
BR9709722B1 (pt) 2010-12-14
WO1997047659A1 (fr) 1997-12-18
CA2258146C (fr) 2003-10-07
FR2749849B1 (fr) 1998-09-04

Similar Documents

Publication Publication Date Title
AU5935986A (en) Microbial polysaccharide articles derived from acetobacter xylinum pellicle
NZ333721A (en) Pharmaceutically acceptable synthetic polysaccharides
AU3266797A (en) Synthetic polysaccharides, method for preparing same and pharmaceutical compositions containing said polysaccharides
BR9304404A (pt) Composiçao aquosa de goma de polissacarídeos, concentrado espumoso antifogo e processo para preparer uma composiçao
FR2617848B1 (fr) Polysaccharides extraits, notamment, de vegetaux utiles comme medicaments et additifs alimentaires
CA2250153A1 (fr) Fibres cellulosiques modifiees a l'aldehyde destinees a des produits papier ayant une resistance initiale elevee a l'etat humide
ATE256137T1 (de) Keratansulfatoligosaccharid-fraktion und sie enthaltendes medikament
AU7824987A (en) Aqueous polysaccharide compositions
CA2079311A1 (fr) Compositions adhesives de .alpha.cyano-acrylate
PT94658A (pt) Processo para a preparacao de composicoes de base polimerica possuindo amido desestruturado e de produtos que as contem
TR26920A (tr) Kisa ya da uzun elyafa dönüstürülmek üzere amaclanmis cam hazirlama yöntemi.
TR199701424T1 (xx) Poliribosilribitolfosfat i�eren a�� bile�imi ve �retim metodu.
MX9705002A (es) Composicion de ensamblaje para hilos de vidrio, procedimiento que utiliza esta composicion y productos resultantes.
DE69805757T2 (de) Polysaccharid, mikroorganismus und verfahren zu dessen herstellung, dieses enthaltende zusammensetzung und verwendung
CA2019675A1 (fr) Polysaccharides cationiques et reactifs pour leur preparation
IE782127L (en) Microbial fractions.
ES8605041A1 (es) Procedimiento de preparacion de polisacaridos membranarios de origen bacteriano
PT1020474E (pt) Derivados de oligossacaridos e processo para a sua obtencao
CA2079018A1 (fr) Un polysaccharide, ses applications, sa production par fermentation et la souche de pseudomonas qui le produit
CA2023058A1 (fr) Compose d'enduction a epaisseurs a base de polygalactomannans a groupes hydrophiles et hydrophobes
BR8806293A (pt) Processo para a preparacao de diorganopolissiloxanos apresentando nas unidades terminais cada uma,um grupo hidroxila si-ligado
GB1409149A (en) Quecetin derivatives and pharmaceutical uses thereof
DE69218067D1 (de) Verfahren zur Herstellung von 3-deacylierten Derivaten eines 16-gliedrigen Macrolid-Antibiotikums, hierfür verwendeter Mikroorganismus, sowie neues Macrolid-Antibiotikum
DE3780080D1 (de) Coccidiozide mittel.
ES8700268A1 (es) Un procedimiento para la preparacion de compuestos de eritromicina 6-0, 11-0, 6-11-di-0-alquilados.

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20170612